Evidence map›Paper›PMID 42290949›Full record

ArticleClinical medicine insights. Pediatrics2026

Current Status of Pediatric Hearing Loss Cases in Oita University Hospital From 2016 to 2019.

Tetsuo Watanabe, Takashi Hirano

Abstract read
In one paragraph

Article in Clinical medicine insights. Pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tetsuo WatanabeDepartment of Otolaryngology Head and Neck Surgery, Oita University Faculty of Medicine, Japan.ORCID https://orcid.org/0000-0002-2041-111X
Takashi HiranoDepartment of Otolaryngology Head and Neck Surgery, Oita University Faculty of Medicine, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The importance and effectiveness of Newborn hearing screening (NHS) have been widely recognized. However, there are a few cases of false-negative NHS results. Hearing loss in children causes various disorders. Therefore, attention should be paid to pediatric hearing loss in clinical otolaryngology. We examined the multiple causes of children referred for detailed hearing loss examination. Methods: This retrospective study included 154 patients, 68 males and 86 females, 3 to 12 years old, referred to our outpatient department between January 2016 and December 2019. We reviewed data on reasons for consultation, newborn hearing screening results, and diagnosis. Results: Seventy-one patients (46.1%) were identified during the health examinations. Seventy-five patients (48.7%) were referred for hearing loss, and 8 (5.2%) were referred for language delay or dysarthria. Most cases are not diagnosed by newborn hearing screening. There were 33 (21.4%) patients who had no hearing loss, 54 (35.1%) had functional hearing loss, 24 (15.6%) had severe-to-profound unilateral hearing loss, 24 (15.6%) had mild to moderate unilateral hearing loss, and 18 (11.7%) had mild to moderate bilateral hearing loss. Of the 66 patients with substantial hearing loss, 40 (61%) had unknown causes and 26 (39%) had middle or inner ear malformations. Conclusions: Appropriate diagnostic imaging is essential in pediatric cases of hearing loss to assess for middle or inner ear malformations. Strategies to address false-negative results in neonatal hearing screening, functional hearing loss, and severe to profound unilateral hearing loss remain important challenges for future clinical practice.

Indexed as

functional hearing lossinner ear malformationmiddle ear malformationnewborn hearing screeningpediatric hearing loss

Identifiers

PMID42290949
PMCPMC13254136

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.